MarketInOut Stock Screener Log In | Sign Up
 

CorMedix Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
CorMedix Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization631.35 mln
Float71.48 mln
Earnings Date11/11/2026

EPS

2.05
Solid

P / E

3.83
Deeply undervalued

Piotroski F-Score

3 / 9
Below average

Beneish M-Score

17.57
Highly suspicious

Relative Strength

88 / 100
Strongly outperforming

Debt / Equity

0.32
Low leverage

Business Description

CorMedix is a New Jersey-based medical company working to protect seriously ill patients from dangerous infections. Its flagship product, DefenCath, is a solution used to clean and seal dialysis catheters, helping to prevent life-threatening bloodstream infections in people with kidney failure. The company has been operating under its current name since 2007.

Key Fundamentals

EPS2.05
P/E3.83
ROE49.31
RPS5.91
ROIC45.61
ROA25.99
Interest Cover78.49
EBITDA, mln242
EV / EBITDA2.50
EV / EBIT2.93
Revenue, mln462
EV / Revenue1.31

Quote Details

Last 7.85
Change -0.25 (-3.09%)
Open 8.01
Volume 894,232
Turnover 7,019,721
Average Volume 1,064,106

Financial Ratios

Pre-Tax Profit Margin44
Leverage Ratio1.96
Current Ratio2.56
Price / Book1.30
Price / Tangible Book8.28
Price / Cash Flow2.50
Price / Free Cash Flow2.85
Debt / Equity0.32
Price / Sales1.54
PEG Ratio5.57

Financial Strength

Altman Z-Score2.32
Piotroski F-Score 3 / 9
Beneish M-Score17.57
Price to Intrinsic Value1.20
Price to Graham Number1.13
Short Ratio17.97
Short % of Float20.05

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 8.13% 96 / 100   
1 Month 1.03% 64 / 100   
2 Months 0.9% 62 / 100   
6 Months 5.8% 71 / 100   
1 Year -29.91% 9 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog